Vancouver, British Columbia, Canada – TheNewswire - April 3, 2025 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) announces the resignation of Tammy Gillis as CFO of the Company. Ms. Gillis will continue to act as a financial consultant to the Company, and in particular, assist with completion of the year end audit process for the last fiscal year.

 

Current director Francisco Kent Carasquero will assume the role of CFO and remain a director of the Company. Mr. Carasquero previously served as the VP Finance of the Company.  Mr. Carasquero has experience in the financial services industry, having served as the Executive Chair of FintechWerx International Software Services Inc. since 2023, co‐founded the payment services company, CPT Secure Inc., of which Mr. Carasquero has been the President since 2016, and through the fintech incubator, Looking Glass Media Limited, of which Mr. Carasquero has been the President and the Chief Financial Officer since 2023. In 2019, Mr. Carasquero co‐founded the ETC3 Tech Centre which provides funding and advisory services for life science, agritech, cleantech and fintech companies. Mr. Carasquero holds a Bachelor of Arts in Economics (Advanced) from the University of Manitoba.

 

About PanGenomic Health

 

PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company’s initial focus is to support mental health. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

 

For more information, please contact:

 

Jerry Lai, Investor Relations                       

PanGenomic Health Inc.       

+1 778 743 4642

ir@pangenomic.com                                       

 

This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic Health and the consideration to be paid to PanGenomic Health. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward looking statements. Although PanGenomic Health believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because PanGenomic Health can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in PanGenomic Health’s disclosure documents which can be found under PanGenomic Health’s profile on www.sedarplus.ca.  Pangenmic Health disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.